Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance
Clinical trial NCT01819389 · COMPLETED
Trial details
- NCT number
- NCT01819389
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.